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Abstract
Injuries to articular cartilage are one of the most challenging issues of musculoskeletal medicine due to the poor intrinsic ability of
this tissue for repair. Despite progress in orthopaedic surgery, the lack of efficient modalities of treatment for large chondral defects
has prompted research on tissue engineering combining chondrogenic cells, scaffold materials and environmental factors. The aim of
this review is to focus on the recent advances made in exploiting the potentials of cell therapy for cartilage engineering. These include:
1) defining the best cell candidates between chondrocytes or multipotent progenitor cells, such as multipotent mesenchymal stromal
cells (MSC), in terms of readily available sources for isolation, expansion and repair potential; 2) engineering biocompatible and
biodegradable natural or artificial matrix scaffolds as cell carriers, chondrogenic factors releasing factories and supports for defect
filling, 3) identifying more specific growth factors and the appropriate scheme of application that will promote both chondrogenic
differentiation and then maintain the differentiated phenotype overtime and 4) evaluating the optimal combinations that will answer
to the functional demand placed upon cartilage tissue replacement in animal models and in clinics. Finally, some of the major
obstacles generally encountered in cartilage engineering are discussed as well as future trends to overcome these limiting issues for
clinical applications.
MESH Keywords Animals ; Biocompatible Materials ; therapeutic use ; Cartilage ; metabolism ; pathology ; Cartilage Diseases ; pathology ; therapy ; Cell Differentiation ;
Chondrocytes ; metabolism ; pathology ; transplantation ; Guided Tissue Regeneration ; Hematopoietic Stem Cell Mobilization ; Humans ; Intercellular Signaling Peptides and
Proteins ; metabolism ; Mesenchymal Stem Cell Transplantation ; Stem Cell Niche ; Tissue Engineering ; Tissue Scaffolds
INTRODUCTION
Structure and function of articular cartilage
Articular cartilage is a highly specialized tissue that reduces joint friction and protects the bone ends from the shear forces associated
with high mechanical load. The articular cartilage consists of chondrocytes and few progenitor cells  which are organized in various[1 ]
layers, from the fibrotic to the mature and hypertrophic mineralizing layer of chondrocytes in direct contact with the sub-chondral bone.
The extracellular matrix (ECM) of chondrocytes is distinct from that of other connective tissues. This ECM is composed of a network of
fibrillar collagens that give the tissue its shape, strength and tensile force and, proteoglycans that give resistance to compression . It[2 ]
contains the large aggregating proteoglycan aggrecan which is attached to hyaluronic acid polymers via a link protein and predominantly,
the collagens type II (80 90  of total collagens), IX and XI. Once the cartilage is formed in the adult, the turn-over of ECM protein– %
replacement is low with a collagen and proteoglycan half-live of 100 and 3 24 years, respectively . This, low rate of matrix remodelling– [3 ]
partly explains why chondrocytes are relatively inactive metabolically although they can respond to various stimuli to maintain normal
homeostasis.
Poor intrinsic capacity of cartilage for repair
After injury due to traumas or osteo-articular diseases, the articular cartilage is frequently damaged resulting in fibrillation and
subsequent degradation which can also lay down into the sub-chondral bone. This is the result of the limited capacity of cartilage for repair
due to the absence of vasculature that cannot provide the progenitor cells from the blood or the bone marrow to enter the tissue.
Accordingly, the resident articular progenitor cells or chondrocytes entrapped within the surrounding matrix do not migrate into the lesions
to secrete a reparative matrix. Consequently, the limited repair capacity and the absence of pharmacological agents have prompted
researchers and surgeons to develop surgical methods to restore cartilage surfaces using tissue grafts or cell-based therapies (for review,
see ). However, none of the current cartilage repair approaches allowed the generation of long term hyaline cartilage replacement tissue.[4 ]
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Limitations of current surgical methods for cartilage repair
Among the possible explanations for the limited results described with the current methods of cartilage repair is the lack of integration
of the chondrocytes within the existing cartilage. This is likely to be due to the insufficient capacity of implanted cells to secrete the
cartilaginous matrix and to recapitulate the complex events resulting in the zonal organization of the cartilaginous tissue . The lack of[5 ]
integration may also be due to the incomplete differentiation of chondroprogenitor cells or instability of the chondrocytic phenotype. The
implantation of undifferentiated cells has already been applied in humans and although a significantly improved patient outcome was
observed after one to five years, the defects were filled with a fibrocartilaginous tissue . Finally, leakage of the cell suspension may be[6 ]
the cause of loss or decreased viability of the implanted cells as currently reported in autologous chondrocyte transplantation . In[7 ]
summary, cell-based therapies have proved their feasibility but showed no superiority over other surgical methods on the long-term
highlighting a crucial need for optimizing various combinations of cell types, scaffolds and/or chondrogenic factors ( ).Fig. 1 
CELL SOURCES FOR CARTILAGE REPAIR
Chondrocytes
Chondrocytes, the resident cells of cartilage, produce the components of the ECM and represent the cells of choice for engineering
articular cartilage. Adult chondrocytes have been isolated from various sources like articular cartilage, nasal septum, ribs or ear cartilage [8
, . However, ear cartilage is an elastic cartilage, which exhibit different mechanical properties as compared to the hyaline cartilage found9 ]
in joint and nasal septuml. Isogai have shown that chondrocytes give rise to cartilage tissue having the characteristics of its originalet al. 
tissue . A chondrocyte from ear cartilage will thus give rise to an elastic cartilage. With a view to an application to the repair of articular[8 ]
cartilage, it therefor seems more appropriate to use hyaline cartilage as a source of chondrocytes. A comparison between different sources
of hyaline chondrocytes (nasal, costal, and articular) has shown the superiority of costal and nasal chondrocytes on articular chondrocytes
in term of quantity of cartilage formed after transplantation in subcutaneous sites . One of the main limits related to the use of[8 ]
chondrocytes, is their instability in monolayer culture resulting in the loss of their phenotype. Indeed, chondrocytes lose the expression of
the chondrocytic markers which are collagen II and aggrecan mainly, but also SZP (superficial zone protein) . This loss of the[10 ]
chondrocytic phenotype is accompanied by a phenotypic shift towards a fibroblastic one. This fibroblastic phenotype is characterized by
an increased expression of collagen I and the adoption of the spindle-shape characteristic of fibroblasts . This process of[11 ]
dedifferentiation is however reversible. Indeed, if dedifferentiated chondrocytes are placed in a three-dimensional environment, they
retrieve their differentiated phenotype , . Chondrocytes from osteoarthritic (OA) cartilage have also been considered. However, OA[12 13 ]
chondrocytes undergo metabolic alterations, which can lead to a low response to inductive environmental factors , . Although[14 15 ]
chondrocytes derived from OA patients appear less appropriate for articular cartilage repair, it has been reported that OA chondrocytes
may be able to recover a normal chondrocytic phenotype after three-dimensional (3D) culture . However, additional studiesin vitro [16 ]
are required to clearly decipher whether OA chondrocytes could be manipulated to be suitable for cell therapy of cartilage.in vitro 
Mesenchymal stem cells
Multipotent mesenchymal stromal cells or mesenchymal stem cells (MSC) are an attractive source of cells for cartilage engineering
due to their easy access and high capacity of expansion. They are mainly isolated from bone marrow or adipose tissue but havein vitro 
been isolated from a number of other tissues including synovium, periosteum, umbilical cord vein or placenta . MSC were first[17 ]
characterized by their clonogenic potential determined by the capacity to form Fibroblast Colony Forming Units (CFU-F). In the bone
marrow, the frequency of CFU-F is in the range of 1 cell in 10 10 mononuclear cells , . They are now characterized by their4 – 5 [18 19 ]
capacity to adhere to plastic, their phenotype (CD73 , CD90 , CD105 , CD14 ou CD11b , CD19 ou CD79 , CD34 , CD45 and +  +  +  −  −  − α  −  −  −
HLA-DR ) and their trilineage differentiation potential . MSC also exhibit the potential to differentiate into myocytes, tendinocytes, − [20 ]
ligamentocytes , cardiomyocytes , neuronal cells ,  and other cell types . More recently, these cells have been[21 ] [22 ] [23 24 ] [25 ]
described as immunoregulatory cells since they were shown to escape the immune recognition and to inhibit the host defence mechanisms
(for review, see ). The interest of various other progenitor cells, such as multipotent adult progenitor cells (MAPC) or marrow-isolated[26 ]
adult multilineage inducible (MIAMI) cells, for cartilage differentiation has been shown in vitro but has still to be validated , in vivo [27 28
.]
DIFFERENTIATION FACTORS REQUIRED FOR CARTILAGE ENGINEERING
A number of growth and differentiation factors that regulate cartilage development and homeostasis of mature articular cartilage have
been identified. The most characterized factors which stimulate the anabolic activity in cartilage include Transforming Growth Factor
(TGF)- , Bone Morphogenetic Protein (BMP), Fibroblast Growth Factors (FGF), Insulin Growth factor (IGF)-1, Hedgehog (hh) andβ
Wingless (Wnt) proteins.
Transforming Growth Factor-  familyβ
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The TGF-  superfamily of polypeptides includes TGF- , BMP, activins and inhibins. Because TGF-  and BMP are the bestβ β β
characterized peptides and their role in osteogenesis and chondrogenesis is well documented , we will focus on these molecules in the[3 ]
following paragraphs. The TGF-  family includes 5 members (TGF- 1 5) which are produced by many different cell types. However, theβ β –
concentration of TGF-  is approximately 100-fold greater in bone than in other tissues . Articular cartilage itself contains largeβ [29 ]
amounts of latent TGF- . Although present in tiny quantities in normal physiological conditions, active TGF- 1, 2 and 3 are generallyβ β
considered to be potent stimulators of proteoglycans and type II collagen synthesis in primary chondrocytes (for review , . In vitro,[3 29 ]
TGF- 1, 2 and 3 were also shown to induce the chondrogenic differentiation of MSC . Recently, rabbit MSC encapsulated withβ [30 –32 ]
thermo-reversible hydrogel releasing heparin-bind TGF- 3 were shown to differentiate toward chondrocytes . In vivo, a porousβ [33 ]
gelatin-chondroitin-hyaluronate scaffold in combination with a controlled release of TGF- 1 could induce the chondral differentiation ofβ
MSCs to form ectopic cartilage . The same group also reported that implantation of rabbit MSC in a full-thickness defect resulted in[34 ]
better chondrocyte morphology, integration, continuous subchondral bone, and much thicker newly formed cartilage layer when compared
to control group . However, several studies have shown that injection of TGF-  or TGF- -expressing adenoviruses results in side[34 ] β β
effects in the joints, such as osteophyte formation, swelling and synovial hyperplasia .[35 –37 ]
Bone morphogenetic proteins
BMPs constitute a large sub-class of polypeptides whose role is essential for chondrogenesis during skeletal development. Indeed,
mutations in and genes result in brachypodism in mice and chondrodysplasia in humans. A number of mice deficient forBMP-5 BMP-14 
BMP are nonviable but in BMPR-IB, ActR-IA, BMP-7 or BMP-14 deficient mice, severe appendicular skeletal defects have been
observed suggesting that they play important synergistic or overlapping roles in cartilage and bone formation in vivo . A number of[38 ]
BMP, including BMP-2, -4, -6, -7, -13, -14 can stimulate the chondrogenic differentiation of MSC  and enhance the synthesis of[39 –42 ]
collagen type II and aggrecan by chondrocytes in vitro . In vivo, healing of full-thickness cartilage defects in the rabbit was improved[43 ]
when combining microfracture and recombinant BMP-7 . Similarly, the implantation of a type I collagen sponge containing[44 ]
BMP-2-expressing naked plasmid DNA implanted in full-thickness cartilage defects stimulates the transfection of MSC subjacent to the
defect and cartilage repair . The use of ex vivo retrovirally transduced muscle-derived stem cells isolated from mouse skeletal muscle[34 ]
to express BMP-4 enhanced chondrogenesis and significantly improved articular cartilage repair in rats . A more recent study[45 ]
indicated that repair of chondral lesions in the knee joints of miniature pigs by periosteal precursor cells is facilitated in deeper hypoxic
zones of cartilage repair tissue and is stimulated by BMP-2, and to a lesser extend IGF-1, which enhance HIF-1  activity . However,α [46 ]
when implanted in ectopic localizations, BMPs led to bone formation via endochondral ossification which should be avoided for articular
cartilage engineering . This observation points to the notion that optimal regulation of BMPs may enhance their efficacy in a regulated[47 ]
tissue engineering strategy. Indeed, Huard s team showed that Noggin delivery can inhibit heterotopic ossification caused by BMP-4,’
demineralized bone matrix, and trauma in calvaria defect model ,  suggesting that this strategy may be also useful for inhibing[48 49 ]
endochondral ossification induced by hypertrophic cartilage. Although these BMP have shown great potential in animal models, no
clinical studies have been conducted to validate their potential to enhance cartilage repair in humans.
Wingless family
The Wnt family of secreted ligands contains more than 20 members in vertebrates that are characterized by conserved cysteine
residues. These proteins exhibit unique expression patterns and distinct functions in development . The Wnt family members signal[50 ]
through the canonical -catenin-dependent pathway or -catenin-independent pathways. Various Wnt members are involved both in earlyβ β
and late skeletal development and play a role in the control of chondrogenesis and hypertrophy. 9 genes are expressed in the postnatalWnt 
growth plate, including and at higher levels, and and at very low levels . Wnt-1,Wnt-4, -5a, -5b, -10b -11 Wnt-2b, -7b, -9a -10a [51 ]
Wnt-4, Wnt-7a, Wnt-8 block chondrogenic differentiation but display different effects on hypertrophy. On the contrary, Wnt-5a and
Wnt-5b promote chondrogenesis , . Wnt-5a together with Wnt-5b were shown to regulate the proliferation of chondrocytes and[52 53 ]
their maturation into hypertrophic chondrocytes in both the embryonic and postnatal growth plate and Wnt-11 does not affect
chondrogenic differentiation. The role of Wnt-3a on chondrogenesis is more controversial. Importantly, we recently identified Wnt-6 as a
new factor able to induce the chondrogenic differentiation of primary MSCs while inhibiting both osteogenic and adipogenic
differentiation (pers.com.). The key genes identified in both embryonic cartilage development and postnatal endochondral bone formation
includes the complex and . It is generally reported that Wnt members responsible for the induction ofWnt-5a/Fz-5 receptor Wnt-7a [54 ]
the osteogenic differentiation activate the -catenin-dependent pathway. Indeed, in vitro inactivation of -catenin in MSC causesβ β
chondrocyte differentiation under conditions allowing only osteoblasts to form . Consistently, in vitro loss- and gain-of-function[55 ]
analyses reveal that  activity is necessary and sufficient to repress the differentiation of mesenchymal cells into Runx2- andβ -catenin 
Sox9-positive skeletal precursors . However, -catenin was recently shown to be required for both osteogenesis and chondrogenesis in[56 ] β
adult mature tissues . Overall, it appears that the Wnt network has dual roles in cartilage, as has been described in other tissues: it is an[57 ]
important regulator of chondrocyte development, but deregulated signaling is detrimental to mature tissues and may lead to disease.
Fibroblast growth factor family
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In vertebrates, the FGF family comprises twenty-two structurally related proteins with a molecular mass from 17 to 34 kDA that bind
one of four tyrosine kinase FGF receptors (FGFR) . The importance of FGF signalling in skeletal development is highlighted by the[58 ]
number of dysplasias, mainly dwarfing chondrodysplasias and craniosynostosis syndromes, attributed to specific mutation in the genes
encoding the FGFR-1, -2 and -3 . During limb development, and are among the earliest genes[59 ] FGFR-2, Sox9 collagen type II 
upregulated in condensing mesenchyme. Mice lacking develop skeletal overgrowth while mice overexpressing an activated formFGFR-3 
of FGFR-3 develop skeletal dwarfism. These data have shown that signalling through FGFR-3 negatively regulates chondrocyte
proliferation through a STAT1 pathway and differentiation through the MAPK pathway. Genetic studies have also identified defects in
chondrogenesis in mice lacking FGF18 whereas no apparent defects in chondrogenesis occurs in mice lacking FGF-2, -5, -6, -7, -8 and
-17. Additionally, the skeletons of mice are sightly smaller than the wild type littermates .FGF-9 /  − − [60 ]
In the adult cells, the chondrogenic effect of FGF and FGFR has been confirmed by very few studies. Indeed, forced expression of 
in the murine C3H10T1/2 MSC line was shown sufficient for chondrogenic differentiation . Accordingly, FGF-18 which wasFGFR-3 [61 ]
shown to be a selective ligand for FGFR-3 in limb bud mesenchymal cells, suppress their proliferation while promoting differentiation to
produce cartilage matrix . In cultured chicken chondrocytes, FGF-9, another ligand for FGFR3, rapidly induces the upregulation and[62 ]
secretion of the matrix phosphoprotein osteopontin, known to be associated with chondrocyte and osteoblast differentiation. Unexpectedly,
FGF-9-induced osteopontin was accompanied by inhibition of differentiation and increased proliferation of the treated chondrocytes .[63 ]
In adult chondrocytes, FGF-2 is mainly mitogenic although recent studies have shown that it can inhibit the anabolic ativities of other
growth factors, such as IGF-1. MSCs expanded in FGF-2-supplemented medium proliferated more rapidly than control MSCs and FGF-2
treatment enhanced subsequent chondrogenic differentiation in a 3-dimensional culture , . In addition, in a rabbit model, FGF-2 can[64 65 ]
stimulate articular cartilage restoration in temporomandibular osteoarthritic defects, although the effective concentration range of FGF-2
would have to be determined . Implantation of a fibrin sealant incorporating FGF-2 successfully induced healing of a mechanically[66 ]
induced defect with hyaline cartilage and concomitant repair of the subchondral bone . One study reports the use of FGF-18 in a[67 ]
setting of rapidly progressive osteoarthritis in rats. The data showed that FGF-18 induced an increase in chondrophyte size and remodeling
of the subchondral bone suggesting that it can stimulate repair of damaged cartilage . The important issues coming from the[68 ]
contradictory results reported to date include a better characterization of the signalling pathways activated by FGFs, a better understanding
of the interplay between these pathways as well as understanding the contribution of additional factors, such as HS, in regulating FGF
activity in cartilage and bone development.
Insulin-like growth factor family
The IGF family is composed of two ligands (IGF-1 and IGF-2), two cell surface receptors (IGF1R and IGF2R), at least six different
IGF binding proteins (IGFBP-1 to IGFBP-6), and multiple IGFBP proteases, which regulate IGF activity in several tissues. IGF-1 is the
most studied form with respect to cartilage repair. In embryonic development, mice with mutations display severe growthIGF-1 /  − −
retardation, have developmental defects in various organs while are 60  smaller than their wild-type littermates but growIGF-2 /  − − %
normally after birth. Accordingly, mice nullizygous for the gene demonstrate severe fetal growth retardation . In humans, aIGF1R [69 ]
reported natural deletion of exons 4 and 5 of the gene results in severe pre- and postnatal growth and developmental deficits,IGF-1 
combined with mental retardation .[70 ]
IGF-1 and IGF1R are expressed by chondrocytes, osteoblasts, and osteoclasts. IGF-1 is considered an essential mediator of cartilage
homeostasis through its capacity to stimulate proteoglycan synthesis and, promote chondrocyte survival and proliferation , . IGF-1[71 72 ]
also induces the differentiation of MSC towards the chondrocytic phenotype as shown by the upregulation of the specific markers , [33 73 ]
. In a critical size full-thickness cartilage defect horse model, defects filled with fibrin clots loaded with IGF-1 repaired better than empty
defects and contained mainly chondrocytes with predominantly collagen type II rich matrix . In the same model, the combined use of[74 ]
chondrocytes and IGF-1 tend to improve the overall continuity and consistency of the repair tissue . However, an age-related or[74 ]
OA-associated decline in the responsiveness of chondrocytes to IGF-1 appears to be due at least in part to over-expression of IGFBPs. The
titration of FGFs by IGFBPs may account for the variable results reported to date with IGF-1 treatment for in vivo cartilage repair studies.
Improvement will require optimizing the dose, injection regimen and/or combination with other growth factors.
Hedgehog family
In mammals, the Hh family comprises 3 members of highly conserved proteins: Sonic hedgehog (Shh), Indian hedgehog (Ihh), and
Desert hedgehog (Dhh). In concert with other signaling molecules, Ihh has been found to function as a central regulator of endochondral
ossification, coordinating chondrocyte proliferation, differentiation, and ossification of the perichondrium. Expression of Ihh induces the
upregulation of a second secreted factor, parathyroid hormone-related protein (PTHrP), which is expressed in distal chondrocytes of the
skeletal elements. Mice overexpressing or a constitutively activated allele of displayed an increased chondrocyte proliferation Ihh Smo [75 
. Furthermore, as Gli3 is the major mediator of Shh signaling during limb patterning, it is not surprising that mutations in the human ] Gli3 
gene cause a variety of inherited skeletal patterning defects . The requirement of Hh signalling varies in different developmental[76 ]
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processes: osteoblast differentiation in the perichondrium and chondrocyte differentiation in the sclerotome are induced by transient
exposures to Ihh or Shh, respectively, whereas the onset of columnar and hypertrophic chondrocyte differentiation depends on continuous
Ihh signaling to maintain the Ihh-PTHrP interactions. Furthermore, hedgehog signaling has been shown to interact with several other
signaling pathways, including those of FGFs, Wnts, and BMPs.
Although hedgedhog signalling has been mainly described in growth plate chondrocytes, the role of Shh during chondrogenesis has
been shown. Indeed, in vitro, Shh-treated MSCs showed expression of cartilage markers aggrecan, Sox9, CEP-68, and collagen type II and
type X within 3 weeks . In addition, Hh pathway dramatically impaired adipogenesis of MSC, with reduced lipid accumulation, a[77 ]
decrease in adipocyte-specific markers, and acquisition of insulin-resistant phenotype stimulation . In vivo, few studies are available[78 ]
and report the role of Shh on bone regeneration .[79 ]
NATURAL AND SYNTHETIC SCAFFOLDS FOR CARTILAGE ENGINEERING
A number of matrices have been tested and in preclinical and clinical studies. These matrices can be classifiedin vitro in vivo 
according to their nature (proteic, polysaccharidic, synthetic and natural) or to their form (mass, mass porous, foam, viscous liquid and
hydrogel). The ideal properties of a matrix are biocompatibility to prevent the inflammatory reactions to protect host tissue;
three-dimensional shape allowing proliferation and cellular differentiation and porosity permitting migration of cells and diffusion of
molecules, nutrients and oxygen. The matrix must also allow cell adhesion to facilitate the implantation of cells in the lesion and
maintainance in the implant. It can also be bioactive and allow the homogeneous and controlled release of growth factors or morphogens.
Finally, the matrix has to adhere to the host tissue; maintain its mechanical integrity in order to avoid its flow after implantation and be
degradable to integrate the physiological processes of tissue remodeling. The matrix must be applicable by mini-invasive surgery thus if
possible injectable. Main matrices used in tissue engineering of the cartilage are referred in . Mixed matrices can be also obtainedtable 1 
either by an association of two or several matrices, or by modifying them chemically or structurally .[80 ]
Natural matrices
Collagen matrices
Collagen-based matrices or collagen sponges are among the mostly used matrices for cartilage engineering. Collagen is naturally
degraded by collagenases and serines proteases. Its degradation is controlled locally by the cells present in the tissue . These collagen[81 ]
matrices implanted alone improve the spontaneous repair process of osteochondral defects in the rabbit . They are however generally[82 ]
associated with chondrocytes  or MSC . MSC seeded in type I and III collagen gels and implanted in osteochondral defects[83 ] [84 ]}
allowed the formation of cartilage and subchondral bone which was mechanically inferior to healthy articular cartilage and showed signs
of degeneration after 24 weeks . Moreover, the use of type I collagen from bovine origin may induce the production of antibodies by[85 ]
the host . Collagen gels like Atelocollagene  (Koken Co Ltd, Tokyo, Japan) are favorable for the culture of chondrocytes and the[86 ] ®
synthesis of the ECM. These gels have been used as three-dimensional support for the culture of autologous human chondrocytesin vitro 
and in humans. This last study showed encouraging results, since 93  of the patients exhibited hyaline cartilage containing type II%
collagen with a biomechanical response similar between repaired tissue and healthy cartilage . Another multicentric clinical study also[87 ]
showed positive preliminary results after implantation of grafts of collagen gel containing autologous chondrocytes and three-dimensional
culture . Collagen gels containing MSC formed hyaline-like tissue in cartilaginous defects after 7 months and after 1 year,in vitro [88 ]
patients had recovered a normal activity . Despite immunoreactivity associated to its bovine origin, collagen gels therefore could appear[6 ]
as suitable matrices for cartilage tissue engineering.
Fibrin Glue
The fibrin adhesive is obtained by polymerization of fibrinogen in the presence of thrombin . The fibrinogen is a physiologic[89 ]
liquid present in blood which is activated to polymerization in vascular lesions or in pathological situations . Physiologically, fibrin[90 ]
promotes the spontaneous repair activity of articular cartilage but also has a pro-inflammatory activity. Fibrin induces its own degradation
by the ECM components into non toxic endpoint components. Several studies have reported that the use of fibrin glue and chondrocytes
improve cartilage repair . In horse, fibrin glue containing either chondrocytes or MSC allowed the formation of a newin vivo [91 –94 ]
cartilaginous tissue containing high proteoglycan and type II collagen contents , . After 30 days, the defects filled with fibrin[95 96 ]
containing MSC exhibited a higher arthroscopic score compared with fibrin alone but it was no more significant after 6 months .[96 ]
Nevertheless, due to its lack of mechanical stability, the use of fibrin glue is restricted. In human, its use is limited to seal off the periosteal
flap in the autologous chondrocyte implantation (ACI) technique .[97 ]
Agarose
Agarose is a polysaccharide which contains residues of L and D-galactose and is isolated from Chinese algae. Agarose has been
mostly used as a matrix for the 3D culture of chondrocytes. It has also been used to help the chondrogenic differentiation of stemin vitro 
cells . Implantation of agarose containing chondrocytes or MSC in osteochondral defects allows the formation of a repaired tissue[98 ]
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containing collagens and proteoglycanes . However, when implanted alone, agarose inhibits the process of spontaneous repair .[99 ] [100 ]
Moreover, due to its weak degradation, agarose has been poorly studied .in vivo 
Alginate
Alginate is a linear polysaccharide purified from brown algae. It can undergo a reversible gelation in aqueous medium by crosslinking
of bivalent cations and its dissolution can be obtained very quickly by using a calcium chelating agent. Alginate has been widely used in
as a matrix for the three-dimensional culture of chondrocytes because it allows the maintenance of the chondrocytic phenotype andvitro 
the synthesis of ECM proteins . In nude mice, the subcutaneous implantation of alginate beads containing MSC differentiated [101 –103 ] in
towards a chondrocytic phenotype allowed the production of cartilaginous protein . the results were disappointing sincevitro [104 ] In vivo, 
alginate alone inhibits spontaneous repair  and when associated with chondrocytes, it did not repair osteochondral defects partly due[105 ]
to severe immunological reactions , . Nevertheless, a hybrid agarose-alginate hydrogel, Cartipatch  (Tissue Bank of France,[106 107 ] ®
Lyon, France), was tested for implantation of autologous chondrocytes in human. After two years, all patients clinically improvedin vivo 
and 8 out of 13 patients had hyaline cartilage in biopsies from neotissue .[108 ]
Hyaluronic acid
Hyaluronic acid (HA) is a component of the cartilaginous ECM which forms macromolecules of important size. HA is degraded
naturally by hyaluronidases  but its degradation products are able to induce chondrolysis . HA-based matrices increase the[81 ] [109 ]
synthesis of ECM by chondrocytes and . Nevertheless, under an unmodified form, HA is not suitable for cartilagein vitro in vivo [110 ]
repair  and needs crosslinking to enhance its biocompatibility . HA may also be associated to other matrices. As an example, a[111 ] [112 ]
tripolymer of gelatine, chondroitin and HA sulphate allowed the maintenance of the chondrocytic phenotype and type II collagen synthesis
. Hyalograft  (Fidia Advanced Biopolymers, Abano Terme, Italy), a tissue engineered graft composed of autologousin vitro [113 ] ©
chondrocytes and HYAFF 11 (Fidia Advanced Biopolymers, Abano Terme, Italy) showed improvement of cartilage function in 91.5  of%
patients .[114 ]
Chitosan
Chitosan is a natural linear polymer pertaining to the glycosaminoglycan (GAG) family. Chitosan is mainly found in cuticules of
arthropods, the endosquelette of cephalopods and in mushrooms. Chitosan can be associated with chondroitin sulphate to form hydrogels [
 and can be degraded by lysosomes . Matrices containing chitosan are biocompatible and are widely used for cellular90 ] [81 ]
encapsulation, drug release and cell culture . Several studies indicate that matrices containing chitosan are able to improve[115 ] in vitro 
cartilage repair, promote chondrogenic activity of human chondrocytes and synthesis of ECM proteins ; when used alone or in[90 ]
association with various other polymers, like alginate or hyaluronic acid . chitosan-based matrices were reported to induce[116 ] In vivo, 
the formation of a hyaline-like repair tissue in articular cartilage defects . To our knowledge, chitosan-based matrices have not yet[117 ]
been evaluated in human.
Cellulose
Cellulose is a semicrystalline polymer of glucose. The cellulose is found in plants and is the most widely spread natural polymer.
Cellulose is degradable by enzymes like cellulases . The biocompatibility of cellulose and its derivatives is well established , [118 ] [119 
. , the use of a cellulose polymer allowed the proliferation of chondrocytes and showed good biocompatibility . In120 ] In vitro [118 ]
addition, we report that injectable hydroxypropylmethylcellulose hydrogel may be used for articular cartilage repair . To date,[121 ]
however, few studies have been performed in this field of tissue engineering.in vivo 
Artificial matrices
Polylactic acid and polyglycolic acid
Polylactic acid (PLA) and polyglycolic acid (PGA) are derived from alpha hydroxypolyesters. PLA and PGA are degraded either by
hydrolysis, or specific cleavage of oligopeptides . Their degradation products are however partially cytotoxic  and these polymers[81 ] [80 ]
induce important immunological reactions , . Originally, they were developed to form resorbable suture wire (vicryl ) and[122 123 ] ™
medical devices (screw, plates). Since twenty years, they are tested alone or mixed with other matrices for cartilage tissue engineering [124
, . Various forms of these polymers, from the fine fibrillary layer to the sponge, have been developed. PGA polymers provide the best 125 ]
results, with a cellular density near of that found and a continuous production of type II collagen . studiesin vitro in vivo [126 ] In vivo 
were mainly performed in the rabbit model . In human, BioSeed  (BioTissue Technologies, Freiburg, Germany) containing[127 ] ®
autologous articular chondrocytes was reported to induce the formation of a hyaline cartilage and to improve significantly clinical scores [
.128 ]
Carbon fibers
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Carbon fibers are inert and therefore did not induce specific biological answer. They were used, without success, to fill rabbit cartilage
defect in order to improve the spontaneous repair . The neotissue was fibrous and exhibited only weak mechanical properties. Despite[129 ]
these unsatisfactory results, carbon fibers have been applied in human with very variable results .[90 ]
Dacron and Teflon
Dacron (polyethylene terephthalate) and Teflon (polytetrafluoroethylene) have been used to improve spontaneous repair of articular
cartilage in rabbit. Results have reported the formation of a repair tissue, which was either a vascularized fibrous tissue or a fibrocartilage [
, . Due to an increased rigidity of joint after resurfacing with Teflon  and immunological reaction observed when these130 131 ] [132 ]
matrices was used as suture wires, these matrices seem not adequate for cartilage tissue engineering.
Hydrogel
The search for a minimally-invasive surgery has justified the development of injectable matrices for cartilage tissue engineering. These
injectable matrices have to be able to solidify, once implanted, to gain the desired shape and present the mechanical properties of the tissue
to repair . Hydrogels are three-dimensional polymeric networks that are able to absorb and retain large volume of water. Viscous[80 ]
polymers from various origins (see ) can be transformed in hydrogel by modifying their environnement. Crosslinking of hydrogelstable 1 
can be initiated by physical stimuli like pH, temperature or ionic environment or chemical crosslink through crossslinking agent,
photopolymerization or enzymatic reaction . Hydrogels generally present good biocompatibility. Moreover, cells, growth factors or[81 ]
bioactives components can be homogeneously incorporated. Their high water content allowed rapid diffusion of nutrients and metabolites [
. Hydrogels are produced from natural or synthetic polymers (see ). Collagen gels represent the main protein based polymer133 ] table 2 –
used for hydrogel production . Among polysaccharide- based polymers, HA , alginate , chitosan  or cellulose[134 ] [114 ] [135 ] [136 ]
derivatives ,  have been used with satisfactory results. Among synthetic polymers, polyvinyl alcohol, polyethylene glycols (PEG)[94 137 ]
and poly(lactide-coglycolide) represent the mostly used. Hydrogels therefore appeared as appealing materials for cartilage tissue
engineering.
CELL THERAPIES IN CLINICS
Therapies currently used or available in clinics are bone marrow stimulation techniques (subchondral drilling , abrasion,[138 ]
microfracture ), multiple osteochondral graft like mosaicplasty  and autologous chondrocyte implantation (ACI) . Clinical[139 ] [140 ] [141 ]
studies report an improvement in clinical outcome measures compared with preoperative assessment but no superiority of one technique
over the others .[142 ]
After a first generation of ACI, a second generation has recently been developed where autologous chondrocytes are associated with a
matrix which provides a three-dimensional environment and support at the implantation site . Various concepts are presently[143 ]
accessible in clinics: MACI (Verigen, Leverkusen, Germany); Maix (Matricel, Hezoenrath, Germany); Chondro-gide (Geistlich ®  ®  ®
Biomaterials, Wolhusen, Switzerland); Atelocollagen (Koken Co Ltd, Tokyo, Japan), Hyalograft C (Fidia Advanced Biopolymers, ®  ®
Abano Terme, Italy), Bio-Seed -C (BioTissue Technologies, Freiburg, Germany). Despite good clinical results, these above mentioned ®
concepts suffer a major limitation related to the fact that matrices require a surgical incision into the joint to be implanted. To address the
issue of less invasive transplantation technique, the development of injectable biomaterials as hydrogels suitable for minimally invasive
transplantation of chondrogenic cells is the focus of current research. The second limitation of the ACI and matrix-induced ACI is the use
of chondrocytes harvested from articular joints which implies a limited quantity of autologous chondrocytes . Therefore, cellular[144 ]
therapies using MSC, an easily accessible source of autologous cells, have been proposed. Only a few case studies have been reported to
date. Transplantation of bone marrowderived MSCs seeded on type I collagen membranes in articular cartilage defects resulted in
increased arthroscopic and histologic grading scores . Centeno . have injected bone marrow-derived MSCs percutaneously in the[145 ] et al 
knee of a patient with radiographic signs of degenerative joint disease . 24 weeks later, they observed a significant cartilage growth[146 ]
and the pain decreased. Kuroda have also transplanted bone marrow MSCs, incorporated in a collagen gel, in an athlete with a gradeet al. 
IV cartilage defect . After seven months, the athlete has regained its normal activity and histologic analysis reveals the formation of[6 ]
hyaline cartilage within the defect. The third study is a three case report where undifferentiated bone marrow-derived MSCs were
associated with collagen sheet . After 1 year, the three patients presented an increase IKDC score (International Knee Documentation[147 ]
Committee) and in 2 patients, a fibrocartilage-like repaired tissue totally recovered the defect . Although the results suggest that[6 ]
autologous MSC transplantation may be an effective approach to promote the repair of articular cartilage defects, improvement is needed
to achieve hyaline cartilage formation. Currently, only one Phase I clinical trial in cartilage tissue engineering using MSCs is underway.
This clinical trial is sponsored by the Royan Institute and Tehran University of Medical Sciences and concerns the use of bone marrow
MSCs mixed with type I collagen scaffolds and implanted in patients with knee cartilage defect or osteoarthritis.
CONCLUSIONS AND FUTURE PERSPECTIVES
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In conclusion, cell-based strategies not only have proved the feasibility of such approaches for cartilage repair but also have provided
good clinical results. However, these protocols are still far from generating a tissue that is comparable to native cartilage with respect to
quality and stability. The use of chondrogenic progenitors, in particular MSCs, will undoubtedly be of high potential for such application.
Nevertheless, more sophisticated approaches combining deliverable bioactive factors together with a chondro-conductive scaffold will be
required ( ). Although some growth factors have been proposed, none are capable to specifically induce the desired lineage and aFig. 2 
timely regulated combination of factors is likely to be required for the obtention of a functional and stable chondrocyte phenotype. These
will rely on the understanding on the complex molecular events involved in chondrogenesis induction and maintenance of the chondrocyte
phenotype taking place during embryogenesis that will have to be reproduced in adult tissue repair.
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Figure 1
Schematic representation of the componants required for cartilage tissue engineering. Cells (stem cells with chondrogenic potential or
chondrocytes), morphogenic factors and scaffolds (natural or synthetic) are combined in vitro to form an engineered scaffold suitable for
implantation. Illustration with permission from Servier ( )http://www.servier.fr/smart/TermsOfUse.asp 
Figure 2
Sequence of events from stem cell isolation to engineered scaffold implantation. The first step is the isolation of mesenchymal stem cell
(MSC) from bone marrow (BM) or adipose tissue (AT) and expansion. This step is followed by the second and third steps of MSCex vivo 
differentiation towards chondrocytes by the addition of morphogenic factors and inclusion into a scaffold, preferentially an injectable
biomaterial that allows an easy and minimally invasive injection of bioengineered scaffold into the cartilage defect as shown in step 4.
Illustration with permission from Servier ( )http://www.servier.fr/smart/TermsOfUse.asp 
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Table 1
Main scaffolds used for the 3-dimensional culture and transplantation of chondrogenic cells in cartilage tissue engineering.
Proteic
Collagen , , , [6 83 87 88 ]
Fibrin , [89 93 –95 ]
Laminin (Matrigel ) , ™ [148 149 ]
Gelatin , [113 150 ]
Polysaccharidic
Agarose [98 –100 ]
Alginate , , [103 105 106 ]
Hyaluronic acid  * [32 ]
Chitosan [115 ]
Cellulose , , [118 121 151 ]
Synthetic
Poly lactic acid , [152 153 ]
Poly glycolic acid [127 ]
Carbon fibres [129 ]
Dacron (polyethylene terephtalate) Teflon (polytetrafluoroethylene) , [130 131 ]
Polyestherurethane [154 ]
Polybutyric acid [155 ]
Polyethylemethacrylate [156 ]
Table 2
Main matrices used to prepare hydrogels for cartilage tissue engineering
Natural
Hyaluronic acid [157 –159 ]
Alginate [160 –162 ]
Chitosan [163 ]
Chondro tin sulfateï [164 ]
Collagen [165 ]
cellulose [121 , 137 ]
synthetic
Poly lactic-co-glycolic [166 , 167 ]
Polyethyleneglycol [168 –170 ]
Polyvinyl alcohol [171 ]
